Tufts Medical Center, INC.

Tufts Medical Center, INC. was paid $164.34M by Medicaid between Jan 2018 and Dec 2024, across 731 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 11% of everything it billed.

33Billing provider infoTUFTS MEDICAL CENTER, INC.
BOSTON, MA 02111

33aNPI1730132515assigned 05/19/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$164.34M

24GClaims4,021,450

24DCodes billed731

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#9 of 66

Median peer was paid$29.11M

This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	653,060	$25.33M
2019	662,416	$23.42M
2020	539,257	$17.41M
2021	686,638	$23.77M
2022	586,450	$24.33M
2023	539,637	$27.81M
2024incomplete	353,992	$22.27M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	11%	125,094	111,220	$17.78M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	9.6%	120,349	106,867	$15.71M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	4.6%	49,438	42,771	$7.59M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.0%	208,790	150,348	$6.55M
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	3.4%	37,883	34,376	$5.52M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.2%	34,393	31,238	$5.29M
96361	Intravenous infusion, hydration; each additional hour	3.1%	13,144	10,910	$5.07M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.8%	27,294	24,409	$4.64M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.8%	33,488	27,172	$4.54M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.4%	16,528	12,279	$3.87M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.1%	5,155	4,996	$3.40M
45380	Colonoscopy, flexible; with biopsy, single or multiple	2.0%	4,284	4,159	$3.26M

719 more codes

G0378	Hospital observation service, per hour	1.8%	25,991	$2.89M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.7%	12,327	$2.84M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.6%	19,482	$2.55M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	1.3%	26,735	$2.11M
99204	Doctor's office visit, new patient (more involved)	1.3%	13,178	$2.08M
99203	Doctor's office visit, new patient (routine)	1.2%	14,141	$1.97M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	30,262	$1.95M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	29,324	$1.52M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	8,090	$1.42M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,561	$1.38M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	9,419	$1.34M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,634	$1.33M
59025	Fetal non-stress test	<1%	5,158	$1.32M
70450	Computed tomography, head or brain; without contrast material	<1%	10,504	$1.30M
96415		<1%	2,738	$1.19M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	20,825	$1.17M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,003	$1.03M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	3,124	$969K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	7,533	$960K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	1,481	$891K
31575		<1%	3,458	$812K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,100	$794K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	6,757	$786K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	24,278	$703K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,442	$680K
99205	Prolong outpt/office vis	<1%	4,439	$679K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	4,708	$653K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	141,735	$637K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,349	$634K
96367		<1%	4,315	$622K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	19,599	$620K
J9271	Injection, pembrolizumab, 1 mg	<1%	60	$613K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	757	$592K
31231		<1%	2,299	$563K
20610		<1%	3,970	$558K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	5,783	$554K
J0178	Injection, aflibercept, 1 mg	<1%	1,220	$552K
67028	Intravitreal injection of a pharmacologic agent	<1%	4,370	$543K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	19,564	$502K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,267	$495K
71046	Radiologic examination, chest; 2 views	<1%	28,539	$493K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	19,080	$489K
76770		<1%	3,025	$481K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	7,385	$479K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	4,553	$475K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	4,817	$472K
17110		<1%	2,070	$468K
74183		<1%	1,514	$461K
90834	Psychotherapy session, about 45 minutes	<1%	13,577	$460K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	4,119	$454K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	3,678	$444K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	3,904	$440K
97803		<1%	6,294	$432K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	4,500	$423K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,279	$421K
76830	Ultrasound, transvaginal	<1%	4,043	$409K
71250		<1%	4,873	$399K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	37,112	$393K
93325		<1%	3,178	$393K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	4,262	$386K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,399	$370K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	9,665	$357K
11900		<1%	1,578	$355K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,478	$344K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	18,816	$342K
97010		<1%	5,822	$341K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,463	$330K
52000		<1%	616	$323K
92567		<1%	9,075	$322K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,824	$316K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	2,980	$316K
84443	Thyroid stimulating hormone (TSH)	<1%	32,127	$303K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,358	$300K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	15,885	$296K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,873	$295K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	5,293	$292K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	2,731	$276K
80053	Comprehensive metabolic panel	<1%	56,291	$274K
76819	Fetal biophysical profile; without non-stress testing	<1%	3,823	$263K
92557		<1%	4,703	$262K
76536		<1%	2,118	$254K
36430		<1%	835	$253K
97162		<1%	3,892	$252K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,989	$249K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	20,392	$245K
90836		<1%	4,877	$240K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	16,680	$237K
83036	Hemoglobin; glycosylated (A1C)	<1%	48,738	$229K
83735		<1%	61,781	$223K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,651	$222K
80051		<1%	70,374	$219K
77080		<1%	4,143	$211K
93971		<1%	954	$209K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	11,782	$207K
76642		<1%	1,742	$204K
97802		<1%	2,653	$197K
92015	Determination of refractive state	<1%	10,067	$193K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	86	$193K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	46,592	$186K
86833		<1%	1,538	$183K
90832	Psychotherapy session, about 30 minutes	<1%	9,616	$178K
85027		<1%	43,022	$177K
93975		<1%	1,273	$177K
90686		<1%	15,100	$176K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	93	$172K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	106	$171K
86480		<1%	4,073	$168K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	17,458	$165K
86832		<1%	1,662	$163K
11102		<1%	368	$161K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	3,275	$154K
84702		<1%	13,801	$152K
87536		<1%	3,775	$151K
92134		<1%	11,568	$149K
90715		<1%	7,409	$143K
87660		<1%	9,311	$141K
82728		<1%	18,173	$141K
80061	Lipid panel	<1%	39,121	$139K
J1453	Injection, fosaprepitant, 1 mg	<1%	751	$138K
20611		<1%	357	$138K
87510		<1%	8,852	$138K
J7050	Infusion, normal saline solution, 250 cc	<1%	7,346	$137K
87480		<1%	8,855	$134K
94010		<1%	1,883	$133K
83970		<1%	8,205	$131K
72100		<1%	4,811	$130K
82565		<1%	80,447	$129K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,527	$129K
0002A		<1%	4,058	$128K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,589	$127K
86780		<1%	12,672	$125K
84484		<1%	15,499	$123K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	23,851	$122K
84520		<1%	77,804	$119K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	568	$118K
92083		<1%	6,570	$117K
80048	Basic metabolic panel (calcium, ionized)	<1%	31,583	$117K
88342		<1%	7,362	$115K
93017		<1%	1,590	$114K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	113	$114K
86850		<1%	19,806	$113K
84466		<1%	15,377	$111K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,671	$111K
0001A		<1%	4,074	$109K
86803		<1%	11,791	$108K
92587		<1%	1,059	$104K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	4,555	$104K
72141		<1%	438	$101K
83880		<1%	6,904	$100K
97161		<1%	1,380	$98K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	75	$97K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,824	$97K
85730		<1%	23,737	$97K
99385		<1%	913	$96K
76801		<1%	870	$95K
82947		<1%	56,341	$95K
71275	Computed tomographic angiography, chest, with contrast material	<1%	513	$93K
82607		<1%	11,719	$92K
84460		<1%	52,528	$91K
85610		<1%	35,118	$90K
92133		<1%	7,684	$90K
94726		<1%	1,589	$89K
96375	Therapeutic injection; each additional sequential IV push	<1%	15,636	$88K
93296		<1%	2,328	$86K
83690		<1%	18,332	$86K
84100		<1%	52,962	$85K
88307		<1%	1,403	$85K
92551		<1%	658	$85K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	22,958	$84K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,909	$84K
76813		<1%	832	$84K
87517		<1%	2,988	$81K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	4,359	$81K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	229	$80K
82247		<1%	44,626	$79K
86140		<1%	23,357	$79K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	36	$78K
11100		<1%	275	$77K
84450		<1%	52,403	$77K
76827		<1%	1,810	$75K
80050	General health panel	<1%	6,096	$75K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,513	$74K
87340		<1%	10,403	$73K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	1,878	$73K
92060		<1%	2,840	$72K
72197		<1%	218	$70K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	66	$69K
20550		<1%	321	$68K
73030		<1%	5,827	$66K
0004A		<1%	2,602	$66K
83540		<1%	17,103	$66K
87086	Culture, bacterial; quantitative colony count, urine	<1%	13,013	$65K
84075		<1%	43,528	$64K
76825		<1%	1,201	$64K
92579		<1%	2,094	$64K
73564		<1%	5,346	$63K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	3,124	$62K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	18	$60K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	2,147	$60K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,461	$59K
92020		<1%	1,171	$59K
92553		<1%	880	$58K
82570		<1%	19,787	$58K
36415	Collection of venous blood by venipuncture	<1%	97,061	$58K
90791	Psychiatric diagnostic evaluation	<1%	606	$57K
94729		<1%	1,855	$56K
86706		<1%	7,939	$56K
86360		<1%	3,312	$56K
86901		<1%	16,945	$55K
64615		<1%	136	$55K
83615		<1%	33,748	$55K
99173		<1%	1,143	$55K
71271		<1%	1,028	$54K
73630		<1%	6,168	$54K
86900		<1%	20,355	$54K
82784		<1%	5,202	$53K
90837	Psychotherapy session, about an hour	<1%	460	$53K
88112		<1%	1,451	$53K
73130		<1%	4,532	$53K
84153		<1%	5,153	$52K
82310		<1%	23,144	$51K
ATP14		<1%	8,466	$50K
81025		<1%	7,163	$50K
84439		<1%	8,381	$49K
91322		<1%	699	$48K
81001		<1%	23,583	$48K
73610		<1%	6,288	$47K
82043		<1%	17,687	$46K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,152	$46K
92555		<1%	1,768	$45K
71045	Radiologic examination, chest; single view	<1%	7,374	$45K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,161	$45K
72050		<1%	1,047	$45K
81002		<1%	24,663	$45K
86359		<1%	3,126	$44K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,349	$43K
84550		<1%	24,432	$43K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	825	$43K
90472	Immunization administration, each additional vaccine (list separately)	<1%	11,150	$43K
82746		<1%	5,614	$42K
70486		<1%	998	$42K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	48	$40K
85652		<1%	20,844	$40K
84480		<1%	4,697	$40K
86334		<1%	2,777	$39K
31579		<1%	63	$39K
83655		<1%	3,410	$39K
70496		<1%	250	$39K
92025		<1%	1,227	$39K
82248		<1%	29,269	$38K
87070		<1%	6,937	$38K
81003		<1%	18,064	$37K
73562		<1%	2,771	$36K
J2704	Injection, propofol, 10 mg	<1%	11,784	$36K
88341		<1%	2,063	$36K
69210		<1%	1,504	$35K
87522	Neg quan hep c or qual rna	<1%	1,376	$35K
82948		<1%	11,697	$35K
73110		<1%	3,965	$35K
ATP07		<1%	5,813	$34K
94060		<1%	263	$33K
84403		<1%	1,953	$33K
93350		<1%	143	$33K
83516		<1%	2,863	$33K
99220		<1%	989	$33K
92550		<1%	446	$32K
90792	Psychiatric diagnostic evaluation with medical services	<1%	335	$32K
90838		<1%	326	$32K
J1756	Injection, iron sucrose, 1 mg	<1%	791	$32K
82105		<1%	3,231	$32K
73502		<1%	3,710	$32K
87799		<1%	2,858	$32K
46221		<1%	39	$31K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	431	$31K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	15,375	$31K
90677		<1%	1,539	$31K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	6,730	$31K
94760		<1%	9,901	$31K
86704		<1%	3,951	$30K
82040		<1%	18,506	$29K
87040		<1%	3,004	$29K
84156		<1%	14,525	$29K
86038		<1%	3,441	$28K
88142		<1%	1,667	$28K
86235		<1%	765	$28K
84155		<1%	9,442	$27K
87186		<1%	5,295	$27K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	5,018	$27K
87653		<1%	1,107	$27K
86762		<1%	2,324	$27K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	29	$26K
86160		<1%	1,689	$26K
Q3014	Telehealth originating site facility fee	<1%	16,912	$24K
85007		<1%	9,348	$24K
80069		<1%	6,273	$23K
91200		<1%	342	$23K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	112	$23K
86923		<1%	620	$23K
73560		<1%	2,048	$23K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	753	$22K
96401		<1%	140	$22K
83001		<1%	1,412	$22K
80076		<1%	8,061	$21K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	77	$21K
77066	Tomosynthesis, mammo	<1%	351	$21K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,708	$21K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	650	$20K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	413	$20K
0064A		<1%	809	$20K
83605		<1%	2,749	$20K
87081		<1%	3,658	$20K
ATP08		<1%	4,627	$20K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	174	$20K
90651		<1%	1,298	$20K
84146		<1%	1,173	$20K
76937		<1%	1,274	$19K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	3,701	$19K
72170		<1%	2,959	$19K
90480		<1%	704	$19K
84165		<1%	3,687	$19K
0012A		<1%	692	$19K
J7030	Infusion, normal saline solution , 1000 cc	<1%	9,374	$19K
86787		<1%	1,848	$19K
77065	Tomosynthesis, mammo	<1%	283	$19K
73080		<1%	1,759	$18K
80197		<1%	5,461	$18K
ATP15		<1%	4,075	$18K
84402		<1%	870	$18K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	13	$18K
82150		<1%	4,269	$18K
J1644	Injection, heparin sodium, per 1000 units	<1%	4,145	$18K
ATP12		<1%	2,742	$18K
51798		<1%	1,241	$18K
82550		<1%	10,017	$18K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,364	$17K
87077		<1%	3,749	$17K
83883		<1%	2,118	$17K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,154	$17K
ATP17		<1%	3,654	$17K
72081		<1%	1,837	$17K
90734		<1%	1,692	$17K
90670		<1%	3,083	$17K
97166		<1%	226	$17K
86580		<1%	922	$17K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	957	$17K
87205		<1%	5,651	$17K
97163		<1%	189	$16K
87486		<1%	701	$16K
97750		<1%	433	$16K
20552		<1%	104	$16K
G0379	Direct admission of patient for hospital observation care	<1%	161	$16K
84703		<1%	2,832	$16K
70491		<1%	129	$16K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	892	$15K
88304		<1%	2,782	$15K
ATP09		<1%	3,111	$15K
87147		<1%	2,793	$15K
58300		<1%	50	$15K
0124A		<1%	662	$15K
87497		<1%	1,303	$15K
85380		<1%	2,076	$14K
88313		<1%	1,810	$14K
J3490	Unclassified drugs	<1%	2,791	$14K
J2505	Injection, pegfilgrastim, 6 mg	<1%	58	$14K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,775	$14K
92523		<1%	78	$14K
83002		<1%	856	$13K
92585		<1%	43	$13K
0011A		<1%	678	$13K
62323		<1%	25	$12K
43235		<1%	14	$12K
85046		<1%	3,636	$12K
90620		<1%	184	$12K
84425		<1%	814	$12K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	3,444	$12K
86039		<1%	1,532	$12K
82670		<1%	491	$12K
64642		<1%	77	$12K
73522		<1%	1,480	$12K
73140		<1%	1,185	$12K
82274		<1%	1,099	$12K
93320		<1%	847	$12K
0072A		<1%	275	$12K
86003		<1%	101	$11K
86225		<1%	1,074	$11K
C9257	Injection, bevacizumab, 0.25 mg	<1%	426	$11K
82652		<1%	432	$11K
99386		<1%	146	$11K
0071A		<1%	267	$11K
0031A		<1%	436	$11K
74018		<1%	550	$10K
92552		<1%	136	$10K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,563	$10K
ATP10		<1%	2,434	$10K
86255		<1%	969	$10K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,171	$9K
0134A		<1%	393	$9K
36591		<1%	1,805	$9K
73590		<1%	2,088	$9K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	75	$9K
85379		<1%	1,406	$9K
10060		<1%	43	$9K
95886		<1%	38	$8K
ATP13		<1%	1,391	$8K
86790		<1%	1,027	$8K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	28	$8K
72040		<1%	416	$8K
83520		<1%	607	$8K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,395	$8K
95816		<1%	27	$8K
83021		<1%	443	$8K
87581		<1%	351	$8K
91300		<1%	8,480	$8K
87088		<1%	1,656	$7K
88185		<1%	34	$7K
77336		<1%	87	$7K
70544		<1%	128	$7K
76818		<1%	142	$7K
93970		<1%	40	$7K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	546	$7K
82435		<1%	491	$7K
87341		<1%	717	$7K
77062		<1%	68	$7K
92582		<1%	343	$7K
97165		<1%	77	$7K
87506		<1%	60	$7K
92250		<1%	1,105	$7K
86431		<1%	1,649	$7K
82610		<1%	1,190	$6K
G0008	Administration of influenza virus vaccine	<1%	4,711	$6K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	342	$6K
11104		<1%	12	$6K
90656		<1%	1,204	$6K
83550		<1%	2,762	$6K
86618		<1%	435	$6K
74021		<1%	484	$6K
90691		<1%	240	$6K
82378		<1%	582	$6K
ATP06		<1%	1,656	$6K
ATP11		<1%	1,493	$6K
51741		<1%	257	$6K
76000		<1%	273	$5K
96405		<1%	101	$5K
86141		<1%	548	$5K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,694	$5K
86304		<1%	481	$5K
70498		<1%	132	$5K
90694		<1%	670	$5K
82951		<1%	478	$5K
84166		<1%	590	$5K
83721		<1%	2,436	$5K
96417		<1%	1,009	$5K
93356		<1%	353	$4K
72082		<1%	255	$4K
76512		<1%	28	$4K
36000		<1%	612	$4K
86200		<1%	454	$4K
82747		<1%	346	$4K
92136		<1%	690	$4K
29580		<1%	83	$4K
76519		<1%	39	$4K
86677		<1%	312	$4K
82803		<1%	307	$4K
94618		<1%	38	$4K
73552		<1%	420	$4K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	691	$4K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	40	$4K
ATP03		<1%	5,323	$4K
77061		<1%	44	$4K
J1815	Injection, insulin, per 5 units	<1%	1,006	$4K
83020		<1%	356	$4K
ATP04		<1%	2,458	$4K
ATP16		<1%	972	$4K
95250		<1%	163	$4K
87802		<1%	393	$4K
96376		<1%	3,699	$4K
12011		<1%	12	$4K
76942		<1%	91	$4K
87102		<1%	477	$4K
82533		<1%	280	$4K
82950		<1%	806	$4K
84436		<1%	678	$4K
11719		<1%	491	$4K
90662		<1%	860	$3K
91306		<1%	658	$3K
76870		<1%	55	$3K
93304		<1%	13	$3K
86765		<1%	300	$3K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	2,140	$3K
77300		<1%	14	$3K
86735		<1%	280	$3K
90474		<1%	1,860	$3K
90733		<1%	51	$3K
12001		<1%	12	$3K
90633		<1%	1,986	$3K
96111		<1%	41	$3K
C1769	Guide wire	<1%	1,673	$3K
0003A		<1%	183	$3K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	198	$3K
87634		<1%	46	$3K
86708		<1%	356	$3K
93880		<1%	39	$2K
87902		<1%	12	$2K
ATP18		<1%	628	$2K
82805		<1%	79	$2K
87338		<1%	207	$2K
10061		<1%	12	$2K
85045		<1%	1,099	$2K
86707		<1%	224	$2K
72131		<1%	60	$2K
86320		<1%	94	$2K
73090		<1%	573	$2K
84590		<1%	254	$2K
90716		<1%	661	$2K
86147		<1%	88	$2K
83521		<1%	228	$2K
96112		<1%	14	$2K
87350		<1%	201	$2K
ATP02		<1%	826	$2K
36592		<1%	3,401	$2K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,817	$2K
81370		<1%	93	$2K
73521		<1%	104	$2K
90653		<1%	263	$2K
86800		<1%	154	$2K
29075		<1%	16	$2K
86146		<1%	82	$2K
0144A		<1%	41	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	560	$2K
90746		<1%	58	$2K
80320		<1%	849	$2K
74019		<1%	119	$2K
83921		<1%	150	$2K
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	73	$2K
84295		<1%	806	$2K
99397		<1%	128	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,211	$2K
95117		<1%	40	$2K
86376		<1%	116	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,017	$1K
82627		<1%	77	$1K
84270		<1%	93	$1K
92556		<1%	39	$1K
ATP05		<1%	349	$1K
85018		<1%	811	$1K
99195		<1%	18	$1K
86335		<1%	138	$1K
86301		<1%	88	$1K
76820		<1%	31	$1K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	2,271	$1K
17000		<1%	42	$1K
90732		<1%	79	$1K
76514		<1%	52	$1K
72110		<1%	145	$1K
99152		<1%	87	$1K
88184		<1%	35	$1K
85384		<1%	190	$1K
A9585	Injection, gadobutrol, 0.1 ml	<1%	694	$1K
82330		<1%	192	$1K
J3590	Unclassified biologics	<1%	29	$1K
20600		<1%	20	$1K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,057	$1K
77072		<1%	26	$1K
89051		<1%	266	$1K
99442		<1%	157	$1K
94664		<1%	40	$1K
90707		<1%	601	$1K
90678		<1%	55	$1K
97535	Self-care/home management training, each 15 minutes	<1%	20	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	942	$1K
83525		<1%	96	$1K
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	<1%	894	$996.06
82465		<1%	678	$995.51
84630		<1%	119	$971.21
87529		<1%	29	$966.64
J3489	Injection, zoledronic acid, 1 mg	<1%	183	$923.53
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	14	$900.00
97804		<1%	12	$880.04
82977		<1%	499	$866.74
88312		<1%	168	$862.95
94762		<1%	256	$857.84
91303		<1%	266	$836.29
93280		<1%	42	$833.93
90680		<1%	2,462	$823.32
82785		<1%	74	$820.06
96161		<1%	64	$787.84
85049		<1%	339	$783.72
76881		<1%	20	$771.42
90649		<1%	1,081	$765.85
86361		<1%	65	$759.15
87116		<1%	90	$732.16
82374		<1%	268	$730.03
76882		<1%	17	$681.34
91301		<1%	784	$669.79
95251		<1%	63	$656.53
84132		<1%	674	$652.24
J1650	Injection, enoxaparin sodium, 10 mg	<1%	138	$650.48
99188		<1%	15	$643.72
86592		<1%	200	$629.65
80299		<1%	62	$596.30
86665		<1%	45	$593.97
94727		<1%	13	$591.82
84445		<1%	13	$556.68
72070		<1%	15	$544.45
82024		<1%	12	$530.70
G0009	Administration of pneumococcal vaccine	<1%	449	$519.71
94761		<1%	1,753	$508.89
80074		<1%	12	$504.12
87449		<1%	77	$503.09
90658		<1%	793	$481.65
J2060	Injection, lorazepam, 2 mg	<1%	316	$477.36
83010		<1%	77	$463.52
99153	Mod sedat endo service >5yrs	<1%	31	$445.00
J1790	Injection, droperidol, up to 5 mg	<1%	677	$442.93
87075		<1%	82	$435.47
99244	Office or other outpatient consultation, moderate to high complexity	<1%	294	$407.33
80329		<1%	851	$397.55
81000		<1%	145	$391.10
87807		<1%	51	$386.38
87206		<1%	108	$385.37
97116		<1%	14	$381.71
86308		<1%	81	$353.52
82525		<1%	39	$350.84
86364		<1%	33	$348.09
86705		<1%	40	$337.82
96127		<1%	295	$326.49
83498		<1%	13	$322.14
90744		<1%	1,715	$320.78
J1630	Injection, haloperidol, up to 5 mg	<1%	64	$313.59
74022		<1%	26	$310.95
76377		<1%	140	$287.99
85014		<1%	299	$285.29
82103		<1%	28	$248.85
86870		<1%	19	$245.81
84305		<1%	12	$232.80
V2632	Posterior chamber intraocular lens	<1%	538	$215.00
86258		<1%	12	$208.70
86381		<1%	12	$202.05
99443		<1%	31	$182.59
84244		<1%	13	$180.54
99243		<1%	109	$176.48
83519		<1%	13	$175.13
86828		<1%	24	$168.98
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	484	$168.73
51701		<1%	29	$154.77
82340		<1%	25	$154.76
82164		<1%	13	$145.77
82010		<1%	31	$144.20
99024		<1%	486	$141.34
0296T		<1%	14	$141.15
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,034	$133.67
93246		<1%	29	$132.12
84432		<1%	13	$124.47
87015		<1%	25	$120.70
86593		<1%	41	$117.65
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	62	$116.17
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	29	$115.52
85390		<1%	14	$114.40
83718		<1%	129	$105.17
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	30	$98.61
80164		<1%	28	$97.86
88300		<1%	97	$93.23
L1820	Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	13	$92.43
84300		<1%	26	$91.87
90698		<1%	2,789	$90.78
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	25	$86.62
82390		<1%	12	$85.23
88311		<1%	14	$72.40
80503		<1%	43	$72.33
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	63	$66.87
87324		<1%	47	$59.05
A4344	Indwelling catheter, foley type, two-way, all silicone or polyurethane, each	<1%	12	$57.90
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	19	$54.00
Q2039	Influenza virus vaccine, not otherwise specified	<1%	120	$50.85
ATP21		<1%	13	$49.28
90710		<1%	602	$48.98
73060		<1%	13	$40.33
93321		<1%	16	$34.75
A4311	Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)	<1%	181	$32.29
91312		<1%	718	$25.07
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	284	$22.95
91313		<1%	422	$3.72
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	201	$3.33
J1171	Injection, hydromorphone, 0.1 mg	<1%	110	$2.56
J1836	Injection, metronidazole, 10 mg	<1%	18	$1.84
J3370	Injection, vancomycin hcl, 500 mg	<1%	119	$0.20
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	181	$0.00
90473		0%	368	$0.00
0690T		0%	394	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	178	$0.00
90785		0%	34	$0.00
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	0%	48	$0.00
90461		0%	15	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	218	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	101	$0.00
11720		0%	12	$0.00
Q0243	Injection, casirivimab and imdevimab, 2400 mg	0%	22	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	26	$0.00
J1245	Injection, dipyridamole, per 10 mg	0%	12	$0.00
91321		0%	128	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	12	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	15	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	14	$0.00
Q0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg	0%	38	$0.00
76981		0%	14	$0.00
90700		0%	12	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	27	$0.00
90657		0%	630	$0.00
46600		0%	26	$0.00
90702		0%	288	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	48	$0.00
90696		0%	532	$0.00
91307		0%	521	$0.00
A4615	Cannula, nasal	0%	12	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	39	$0.00
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	0%	13	$0.00
99406		0%	13	$0.00
81599		0%	13	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDONOVAN, STEVE (DIRECTOR OF FINANCIAL PLANNING)

Same official

Other billing entities under DONOVAN, STEVE

Full network →

Provider	Location	Paid
Tufts Medical Center, INC.	Boston, MA	$3.81M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.